A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein

Por Landeck, Natalie, Hall, Hélène, Ardah, Mustafa T., Majbour, Nour K., El-Agnaf, Omar M. A., Halliday, Glenda, Kirik, Deniz
Publicado no Mol Neurodegener (2016)

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease

Por Majbour, Nour K., Chiasserini, Davide, Vaikath, Nishant N., Eusebi, Paolo, Tokuda, Takahiko, van de Berg, Wilma, Parnetti, Lucilla, Calabresi, Paolo, El-Agnaf , Omar M. A.
Publicado no Sci Rep (2017)

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease

Por Hansson, Oskar, Hall, Sara, Öhrfelt, Annika, Zetterberg, Henrik, Blennow, Kaj, Minthon, Lennart, Nägga, Katarina, Londos, Elisabet, Varghese, Shiji, Majbour, Nour K, Al-Hayani, Abdulmonem, El-Agnaf, Omar MA
Publicado em 2014

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease

Por Parnetti, Lucilla, Farotti, Lucia, Eusebi, Paolo, Chiasserini, Davide, De Carlo, Claudia, Giannandrea, David, Salvadori, Nicola, Lisetti, Viviana, Tambasco, Nicola, Rossi, Aroldo, Majbour, Nour K., El-Agnaf, Omar, Calabresi, Paolo
Publicado em 2014

Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders

Por Javed, Hayate, Menon, Sindhu A, Al-Mansoori, Karima M, Al-Wandi, Abdelmojib, Majbour, Nour K, Ardah, Mustafa T, Varghese, Shiji, Vaikath, Nishant N, Haque, M Emdadul, Azzouz, Mimoun, El-Agnaf, Omar MA
Publicado no Mol Ther (2016)

Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers

Por Aasly, Jan O., Johansen, Krisztina K., Brønstad, Gunnar, Warø, Bjørg J., Majbour, Nour K., Varghese, Shiji, Alzahmi, Fatimah, Paleologou, Katerina E., Amer, Dena A. M., Al-Hayani, Abdulmonem, El-Agnaf, Omar M. A.
Publicado em 2014

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease

Por Majbour, Nour K., Vaikath, Nishant N., van Dijk, Karin D., Ardah, Mustafa T., Varghese, Shiji, Vesterager, Louise B., Montezinho, Liliana P., Poole, Stephen, Safieh-Garabedian, Bared, Tokuda, Takahiko, Teunissen, Charlotte E., Berendse, Henk W., van de Berg, Wilma D. J., El-Agnaf, Omar M. A.
Publicado no Mol Neurodegener (2016)

Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration

Por Duffy, Megan F., Collier, Timothy J., Patterson, Joseph R., Kemp, Christopher J., Luk, Kelvin C., Tansey, Malú G., Paumier, Katrina L., Kanaan, Nicholas M., Fischer, Luke D., Polinski, Nicole K., Barth, Olivia L., Howe, Jacob W., Vaikath, Nishant N., Majbour, Nour K., El-Agnaf, Omar M. A., Sortwell, Caryl E.
Publicado no J Neuroinflammation (2018)

Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration

Por Duffy, Megan F., Collier, Timothy J., Patterson, Joseph R., Kemp, Christopher J., Luk, Kelvin C., Tansey, Malú G., Paumier, Katrina L., Kanaan, Nicholas M., Fischer, D. Luke, Polinski, Nicole K., Barth, Olivia L., Howe, Jacob W., Vaikath, Nishant N., Majbour, Nour K., El-Agnaf, Omar M. A., Sortwell, Caryl E.
Publicado no J Neuroinflammation (2018)

Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects

Por Tomlinson, Julianna J., Shutinoski, Bojan, Dong, Li, Meng, Fanyi, Elleithy, Dina, Lengacher, Nathalie A., Nguyen, Angela P., Cron, Greg O., Jiang, Qiubo, Roberson, Erik D., Nussbaum, Robert L., Majbour, Nour K., El-Agnaf, Omar M., Bennett, Steffany A., Lagace, Diane C., Woulfe, John M., Sad, Subash, Brown, Earl G., Schlossmacher, Michael G.
Publicado no J Neural Transm (Vienna) (2017)